Methods for treating obesity with a combination comprising a MTP inhibitor and a cholesterol absorption inhibitor

Details for Australian Patent Application No. 2007338625 (hide)

Owner Aegerion Pharmaceuticals, Inc.

Inventors Wisler, Gerald L.

Agent Pizzeys

Pub. Number AU-A-2007338625

PCT Pub. Number WO2008/079398

Priority 60/876,280 21.12.06 US

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/437 (2006.01)

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

9 July 2009 PCT application entered the National Phase

  PCT publication WO2008/079398 Priority application(s): WO2008/079398

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338627-Surgical applications for BMP binding protein

2007338622-Process for assembling a loading tube